Perjury charges added in new indictment against pharma rep in fraud case
Jul. 5—An indicted former pharmaceutical rep who has said he can't afford to pay for a new round of legal defense costs now faces additional charges that his public defender will have to deal with: lying about his money.
A federal grand jury indicted
The new indictment includes the conspiracy to commit health care fraud charge and 11 money laundering counts that were in his initial indictment. In addition to the three perjury charges, the new indictment adds three money laundering counts.
Luehrsen waived personally appearing at his arraignment Wednesday, pleading not guilty to all the charges in a signed form he submitted to the court.
In 2020, the government seized most of Luehrsen's assets, taking between
In
Prosecutors raised concerns about Luehrsen's truthfulness in
But prosecutors at the time said the court should be "highly skeptical of Luehrsen's claim to be destitute."
The government learned that Luehrsen failed to disclose an interest he owned in
"The affidavit Luehrsen submitted as part of his current (motion to get back seized funds) now acknowledges that he sold his interest in
The perjury charges stem from what Luehrsen allegedly said of his financial gains from the nightclub.
According to the new indictment, Luehrsen allegedly lied:
In
In
In
Like the previous indictment, Luehrsen is accused of generating millions of dollars in wrongful insurance reimbursements through his company, MedHype, by orchestrating a pyramid operation to get prescriptions for non-narcotic, custom-made creams for scars, wounds and pain. The compound medications that included highly priced ingredients were prescribed without doctors even seeing many of the patients, according to the new indictment.
He and others received exorbitant reimbursements from insurers — sometimes as much as
Prosecutors say Luehrsen recruited others to look for patients with certain insurance coverages and doctors willing to sign prescriptions for custom medications, even if the patients didn't need them.
In one case cited by prosecutors, non-narcotic creams for scars, wounds and pain sent to one family cost an insurance plan more than
One doctor signed 147 compound medication prescriptions for 19 patients but only examined two of the patients. The prescriptions were filled 519 times resulting in more than
From 2014 through 2016, Luehrsen received more than
Luehrsen's lawyers during his first trial told jurors that the health insurance companies — not Luehrsen — set the prices for the compound medications.
"The health insurance companies, who are the alleged victims here, decided what they were willing to pay for different compound medications," defense attorney A. Lee Bentley III told jurors during his opening statement. "They set the prices. They were perfectly free at any time to discontinue coverage."
___
(c)2023 The Buffalo News (Buffalo, N.Y.)
Visit The Buffalo News (Buffalo, N.Y.) at www.buffalonews.com
Distributed by Tribune Content Agency, LLC.



Michael Baumstein joins Martello Re as Chief Investment Officer and Chief Financial Officer; Virginia Perinelli and Alana Rathbun receive promotions
Four suspects indicted for allegedly filing fraudulent unemployment claims of $700,000 during pandemic
Advisor News
- Women say their advisors respect them, but talk down to them
- How PEPs compare with traditional 401(k)s
- Allianz studies why 42% of Americans retire sooner than expected
- Why advisors should be talking about life settlements
- Millennials are ready to bring their advisor to the family table
More Advisor NewsAnnuity News
- NAIC regulators continue pushing for annuity illustration updates
- Wink: Flat first-quarter annuity sales fall just short of $100B
- 26North Re Agrees to Acquire 100% of Independent Insurance Group
- Matthew Michelini named Athene president, with an eye on annuity growth
- Lincoln Financial Announces Executive Leadership Transitions
More Annuity NewsHealth/Employee Benefits News
- New Findings on Soft Tissue Sarcomas from National Cancer Center Research Institute Summarized (Differences Among Genomic Profiling Tests for Bone and Soft-Tissue Sarcomas in a Universal Health Insurance System): Oncology – Soft Tissue Sarcomas
- New Clinical Oncology Findings from Basit Chaudhry and Co-Authors Described (Biosimilar adoption and provider performance in Medicare value-based payment models): Clinical Oncology
- Arizona AG Mayes accuses health insurance companies of price fixing
- Tom Campbell: We're paying too much for poor health care
- Self-pay and dental care: Can paying cash without insurance help you save?
More Health/Employee Benefits NewsLife Insurance News
- Prudential announces more layoffs as insurer continues to restructure
- Pradip Patiath Joins Securian Financial Board of Directors
- Over $107 million in life insurance benefits located for Tennesseans in 2025
- Study Data from National Institutes of Health Provide New Insights into Law and the Biosciences (Taking actuarial fairness seriously: what is required for the ethical use of genetics in insurance?): Legal Issues – Law and the Biosciences
- 26North Re Agrees to Acquire 100% of Independent Insurance Group
More Life Insurance News